Trial intelligence / Profile preview

Impact of EVICEL biological glue on perioperative bleeding in total knee arthroplasty

2009-010802-12Phase 4Active

Sponsor
Clinique Mutualiste Chirurgicale de la Loire
Start
Sep 2009
Modality
Recombinant Proteins and Enzymes, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Countries
1
01

Overview

Phase 4 trial of porcine fibrin sealant in knee osteoarthritis (OA), sponsored by Clinique Mutualiste Chirurgicale de la Loire. Primary endpoint: Perioperative bleeding loss (Gross formula). Started Sep 2009; status: active.

02

Drugs

porcine fibrin sealant
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on 2009-010802-12.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-010802-12.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call